Emars Perk Allen Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 1.00 M
- Company Age 47 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.99 M
- Revenue Growth -85.50%
- Profit Growth -96.63%
- Ebitda -169.51%
- Net Worth 17.01%
- Total Assets -28.20%
About Emars Perk Allen
Emars Perk Allen Private Limited (EPAPL) is a Private Limited Indian Non-Government Company incorporated in India on 26 December 1977 and has a history of 47 years and one month. Its registered office is in Kolkata, West Bengal, India.
The Corporate was formerly known as Emars Allen Pharma Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹7.99 M.
Gour Sarkar and Shashanka Sarkar serve as directors at the Company.
Company Details
-
Location
Kolkata, West Bengal, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U51909WB1977PTC031282
-
Company No.
031282
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
26 Dec 1977
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Emars Perk Allen?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shashanka Sarkar
|
Managing Director | 25-Sep-2006 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Gour Sarkar
|
Director | 01-Jan-2005 | Current |
Financial Performance of Emars Perk Allen.
Emars Perk Allen Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 85.5% decrease. The company also saw a substantial fall in profitability, with a 96.63% decrease in profit. The company's net worth Soared by an impressive increase of 17.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Emars Perk Allen?
In 2023, Emars Perk Allen had a promoter holding of 70.40% and a public holding of 29.60%. The company had 1 Subsidiary and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Jupiter Pharmaceuticals LtdGour Sarkar is a mutual person
-
Allen Healthcare Co LimitedGour Sarkar is a mutual person
-
Allen's India Ltd.Gour Sarkar and Shashanka Sarkar are mutual person
-
Allen Laboratories LtdGour Sarkar and Shashanka Sarkar are mutual person
-
Allen Ad & Publicity Private LimitedGour Sarkar is a mutual person
-
Allen Aqua Food & Drug Private LimitedGour Sarkar is a mutual person
Charges (Loans)
₹0.80 Cr
₹0
Charges Breakdown by Lending Institutions
- Hdb Financial Services Limited : 0.45 Cr
- Others : 0.35 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Aug 2019 | Others | ₹3.46 M | Open |
| 20 Jun 2014 | Hdb Financial Services Limited | ₹4.53 M | Open |
How Many Employees Work at Emars Perk Allen?
Emars Perk Allen has a workforce of 1 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Emars Perk Allen, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Emars Perk Allen's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
